Estimate Recalculated Nov 1, 2024 02:23PM EST
Daniel B Soland has an estimated net worth of $10.6 Million. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., ACADIA PHARMACEUTICALS INC, IDERA PHARMACEUTICALS, INC., DBV Technologies S.A., VIROPHARMA INC, and CHIRON CORP.
Daniel B Soland's CIK is 0001318485
2012 was Daniel B Soland's most active year for acquiring shares with 6 total transactions. Daniel B Soland's most active month to acquire stocks was the month of May. 2014 was Daniel B Soland's most active year for disposing of shares, totalling 24 transactions. Daniel B Soland's most active month to dispose stocks was the month of December. 2013 saw Daniel B Soland paying a total of $1,027,486.24 for 221,732 shares, this is the most they've acquired in one year. In 2014 Daniel B Soland cashed out on 918,992 shares for a total of $7,881,088.60, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!